Varian’s IDE win makes way for first ever FLASH therapy clinical trial

By Nikita Chaurasia  Date: 2020-10-13

Varian’s IDE win makes way for first ever FLASH therapy clinical trial

U.S.-based radiotherapy technology company, Varian Medical Systems has made it to the headlines for reportedly receiving an IDE (Investigational Device Exemption) from the U.S. Food & Drug Administration.

For the uninitiated, FLASH therapy is an innovative radiation treatment that involves ultra-high dose rates of radiotherapy. The study, named FAST-01, will conduct the investigation using Varian's ProBeam particle accelerator which is apparently modified with a specialized module with FLASH capabilities.

If reports are to be believed, the trial will involve over 10 patients with bone metastases and evaluate parameters such as side-effects, efficacy of the treatment and clinical workflow feasibility. In fact, preclinical trials conducted by Varian suggested that the new technology is significantly faster and causes lesser tissue damage as compared to conventional radiotherapy.

It is to be noted that Varian has supported the FlashForward Cosortium, a 20-member group of institutions from across the globe, that includes experts in translational sciences, radiation oncology and medical physics.

Speaking of the trials, President of Proton Therapy Solutions and Chief Growth Officer at Varian, Kolleen Kennedy, was reported saying that the company’s advancement in FLASH therapy is a testament to their investments and efforts towards improving cancer treatment.

Dr. Deepak Khuntia, Chief Medical Officer and Senior VP of Varian mentioned in a comment that the investigation is vital proof of concept, particularly in deep-seated as well as superficial tumors. It will impart a thorough understanding regarding the operations of FLASH therapy , he added.

Sources close to the matter claim that the patient enrollment in the FAST-01 Feasibility Study is expected to commence by the end of the year 2020.

About Varian Medical Systems

California-headquartered Varian Medical Systems is a radiation oncology treatments and software company and focuses on developing innovative cancer care technologies and solutions.

With over 10,000 employees across 70 locations, the company harnesses advanced technologies such as machine learning, AI (artificial intelligence) and data analytics in order to enhance cancer treatment.

 

Source credits: https://www.prnewswire.com/news-releases/varian-receives-investigational-device-exemption-ide-and-prepares-for-first-ever-clinical-trial-of-flash-therapy-301149339.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Apple unveils 16-inch MacBook Pro with high-performance M1 processors

Apple unveils 16-inch MacBook Pro with high-performance M1 processors

By Nikita Chaurasia

Tech giant Apple, Inc. has recently unveiled the 16-inch MacBook Pro, which promises extraordinary design and performance. The model can be customized with the all-new M1 Pro and M1 Max processors.    These new 10-core processors are ...

Kedrion Biopharma expands to North America with Prometic acquisition

Kedrion Biopharma expands to North America with Prometic acquisition

By Nikita Chaurasia

Prometic Life Sciences has developed the first FDA-approved treatment for Congenital Plasminogen Deficiency. This acquisition will enable easy access to advanced therapies for patients suffering from this rare disease. Kedrion Biopharma Inc. has...

Facebook Pages to reduce focus on Likes and followers for Indian users

Facebook Pages to reduce focus on Likes and followers for Indian users

By Nikita Chaurasia

Facebook Inc. has reportedly removed Likes from Facebook Pages for its Indian users to make the platform more user-friendly and easier to understand. This redesign of Facebook Pages was launched in January 2021 and has been rolled out for Indian user...

Merchant commerce platform Pine Labs eyeing USD 1 Bn Nasdaq listing

Merchant commerce platform Pine Labs eyeing USD 1 Bn Nasdaq listing

By Nikita Chaurasia

India is likely to witness a record number of IPOs this year, with several companies eyeing public listing to raise funds if the market sentiment remains positive. One such company, Pine Labs is reportedly planning to list itself on Nasdaq by October...

European climate group asks EU for tougher CO2 targets for truck makers

European climate group asks EU for tougher CO2 targets for truck makers

By Nikita Chaurasia

According to a recent study conducted by Europe’s Transport and Environment (T&E), the European Union (EU) should implement stricter CO2 targets for truck makers to swiftly transition to zero-emission models as present goals do not provide ...